Mivacurium
- TRADE NAME: Mivacron (GSK)
- INDICATIONS: Adjunct to general anesthesia
- CLASS: Nicotinic antagonist
- HALF-LIFE: 1.8–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetazolamide, Aminoglycosides, Anticholinesterases, Bambuterol, Calcium channel blockers, Chloroquine, Chlorpromazine, Clindamycin, D-Penicillamine, Ecothiophate iodide, Enflurane, Furosemide, Halothane, Hexomethonium, Isoflurane, Ketamine, Lidocaine, Lincomycin, Lithium salts, Magnesium salts, Mannitol, MAO inhibitors, Organophosphates, Pancuronium, Phenytoin, Polymyxins, Procainamide, Quinidine, Sevoflurane, Spectinomycin, Tetracyclines
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
LOCAL.
NEUROMUSCULAR/SKELETAL.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric